Open AccessCYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
Author(s) -
Е. Н. Имянитов,
Т. Ю. Семиглазова
Publication year - 2017
Publication title -
opuholi ženskoj reproduktivnoj sistemy
Language(s) - English
Resource type - Journals
eISSN - 1999-8627
pISSN - 1994-4098
DOI - 10.17650/1994-4098-2017-13-4-34-43
Subject(s) - palbociclib , metastatic breast cancer , medicine , oncology , breast cancer , cyclin dependent kinase 4 , estrogen receptor , endocrine system , estrogen , cancer research , cancer , cyclin dependent kinase , pharmacology , hormone , cyclin dependent kinase 2 , cell cycle